enGene Holdings Target Price

Analysts' average 12-month price target for enGene Holdings is $3.5.

Get informed when a big investor buys or sells

+ Follow

Share Price

$1.94

Average Target Price

$3.50

80.4% upside

2 analysts in the last 4 months

High: $4 | Low: $3

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-06-18	Morgan StanleyJudah Frommer	$3	54.6% upside
2026-06-16	H.C. WainwrightAndres Maldonado	$4	106.2% upside
2026-05-14	UBS	$2	3.1% upside
2026-05-08	Leerink PartnersMarket Perform	$2	3.1% upside
2026-05-08	Raymond James	$4	106.2% upside
2026-05-08	Piper SandlerAllison Bratzel	$4	106.2% upside
2026-05-08	Wells Fargo	$2	3.1% upside
2026-03-09	Raymond JamesSean McCutcheon	$27	1291.8% upside
2026-01-30	Jefferies	$28	1343.3% upside
2025-12-03	H.C. WainwrightAndres Maldonado	$25	1188.7% upside
2025-11-12	OppenheimerLeland Gershell	$33	1601% upside
2025-11-12	UBS	$10	415.5% upside
2024-11-18	JMP SecuritiesSilvan Tuerkcan	$18	827.8% upside
2024-09-27	Leerink PartnersMani Foroohar	$17	776.3% upside

enGene Holdings (ENGN) FAQ

enGene Holdings's target price stands at $3.5. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $3.5 for ENGN implies 80.4% upside versus today's price ($1.94). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how enGene Holdings's target price evolved across reporting periods, while the comparison chart places ENGN next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.